Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma
Open Access
- 26 March 2010
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 8 (1) , 30
- https://doi.org/10.1186/1479-5876-8-30
Abstract
The oncoprotein Epstain-Barr Virus (EBV)-encoded latent membrane protein1 (LMP1) modulates the pathological effects of the NF-κB, AP-1 and JAK/STAT pathways in nasopharyngeal carcinoma (NPC).This publication has 36 references indexed in Scilit:
- Relation between outcomes and localisation of p-mTOR expression in gastric cancerBritish Journal of Cancer, 2009
- mTOR: dissecting regulation and mechanism of action to understand human diseaseBiochemical Society Transactions, 2009
- Epstein-Barr Virus-Encoded LMP1 Regulates Epithelial Cell Motility and Invasion via the ERK-MAPK PathwayJournal of Virology, 2008
- Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinomaJournal of Translational Medicine, 2008
- Epstein–Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3KOncogene, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategiesTrends in Microbiology, 2004
- Molecular characterization of epstein‐barr virus and oncoprotein expression in nasopharyngeal carcinoma in KoreaHead & Neck, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomasEuropean Journal Of Cancer, 1995